Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) -- Wacoal, the nation’s leading designer intimate apparel brand, today announced its Spring 2026 Fit for the Cure® events in partnership with Susan G....
-
OCALA, Fla., March 04, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and...
-
Fort Wayne Medical Oncology and Hematology and Cameron Health Partner to Increase Access to Community Cancer Care in Angola, Indiana
-
EDAP to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026 Company to host conference call and webcast on Wednesday, March 25 at 8:30 a.m. EDT AUSTIN, Texas, March 4,...
-
Ramat Gan, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary small...
-
Nationwide media tour conducted by Wacoal, in conjunction with D S Simon Media, discussing Fit for the Cure® Celebrates 25 Years: Wacoal hosts 400+ nationwide events supporting Susan G. Komen’s direct...
-
Preclinical data shines: >85% tumor growth inhibition in pancreatic models, reduced fibrosis and resistance markers, and a gentler safety profile
-
OCALA, Fla., March 02, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced an agreement with the PPD™ clinical research business of Thermo...
-
OCALA, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and...
-
ICPO und UroTeragLATAM gehen strategische Partnerschaft ein, um Theranostik für urologische Krebserkrankungen in Lateinamerika zu fördern